Literature DB >> 10464163

Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development.

S Hashimoto1, H Nishizumi, R Hayashi, A Tsuboi, F Nagawa, T Takemori, H Sakano.   

Abstract

During the development of lymphocytes, expression of the Ig genes is strictly regulated in a tissue-specific manner and in a time-ordered fashion. We have previously shown that the PU.1 binding motif in the Igkappa 3' enhancer (kappaE3') and a novel Ets family protein other than PU.1 may be possibly involved in the control of V(kappa)-J(kappa) joining. In the attempt to isolate the novel Ets family protein, we have screened cDNA libraries with the yeast one-hybrid method and identified a new PU.1-related factor, Prf. This novel Ets family protein is shown to interact with the PU.1 binding sequences in various promoters and enhancers, including kappaE3'. It was found that expression of the prf gene is predominant in the B-lineage cells, with the exception of immature B cells. Since Prf does not exhibit functions of transcriptional activity, this novel protein may act as an antagonist against other Ets family proteins, e.g. PU.1 and Spi-B. Possible roles of Prf with respect to the B cell differentiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464163     DOI: 10.1093/intimm/11.9.1423

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling.

Authors:  Xiang Zhu; Brock L Schweitzer; Eric J Romer; Courtney E W Sulentic; Rodney P DeKoter
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

Review 2.  At the intersection of DNA damage and immune responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Nat Rev Immunol       Date:  2019-04       Impact factor: 53.106

3.  Spi-B can functionally replace PU.1 in myeloid but not lymphoid development.

Authors:  Richard Dahl; Diana L Ramirez-Bergeron; Sridhar Rao; M Celeste Simon
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

4.  Evolution of hematopoiesis: Three members of the PU.1 transcription factor family in a cartilaginous fish, Raja eglanteria.

Authors:  M K Anderson; X Sun; A L Miracle; G W Litman; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

5.  EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.

Authors:  Haidan Liu; Zhi Duan; Hui Zheng; Duosha Hu; Ming Li; Yongguang Tao; Ann M Bode; Zigang Dong; Ya Cao
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

6.  Opposing Roles for the Related ETS-Family Transcription Factors Spi-B and Spi-C in Regulating B Cell Differentiation and Function.

Authors:  Anne-Sophie Laramée; Hannah Raczkowski; Peng Shao; Carolina Batista; Devanshi Shukla; Li Xu; S M Mansour Haeryfar; Yodit Tesfagiorgis; Steven Kerfoot; Rodney DeKoter
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

7.  RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex.

Authors:  Deepti Soodgupta; Lynn S White; Wei Yang; Rachel Johnston; Jared M Andrews; Masako Kohyama; Kenneth M Murphy; Nima Mosammaparast; Jacqueline E Payton; Jeffrey J Bednarski
Journal:  Cell Rep       Date:  2019-10-22       Impact factor: 9.995

8.  Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis.

Authors:  Masako Kohyama; Wataru Ise; Brian T Edelson; Peter R Wilker; Kai Hildner; Carlo Mejia; William A Frazier; Theresa L Murphy; Kenneth M Murphy
Journal:  Nature       Date:  2008-11-26       Impact factor: 49.962

9.  RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.

Authors:  Jeffrey J Bednarski; Ruchi Pandey; Emily Schulte; Lynn S White; Bo-Ruei Chen; Gabriel J Sandoval; Masako Kohyama; Malay Haldar; Andrew Nickless; Amanda Trott; Genhong Cheng; Kenneth M Murphy; Craig H Bassing; Jacqueline E Payton; Barry P Sleckman
Journal:  J Exp Med       Date:  2016-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.